Chromosomal localization in mouse and human of the vasoactive intestinal peptide receptor type 2 gene: A possible contributor to the holoprosencephaly 3 phenotype

Genomics

Volumn 37, Issue 3, 1996, Pages 345-353

  Mackay, M ^a   Fantes, J ^b   Scherer, S ^c   Boyle, S ^b   West, K ^a   Tsui, L C ^c   Belloni, E ^c   Lutz, E ^a   Van Heyningen, V ^b   Harmar, A J ^a  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 12; CHROMOSOME 7Q; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HOLOPROSENCEPHALY; HUMAN; HUMAN CELL; MONOSOMY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

GENETTA;

EID: 0030298335     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1996.0569     Document Type: Article

References (50)

1. Barr, M., Hanson, J. W., Currey, K., Sharp, S., Toriello, H., Schmickel, R. D., and Wilson, G. N. (1983). Holoprosencephaly in infants of diabetic mothers. J. Pediatr. 102: 565-568.
2. Belloni, E., Scherer, S. W., Siegel-Bartelt, J., Frumkin, A., Donis-Keller, H., Helms, C., Hing, A. V., Roessler, E., Barnoski, B., Mitchell, H., Muenke, M., and Tsui, L.-C. (1995). Characterization of the holoprosencephaly minimal critical region at 7q36. Am. J. Hum. Genet. 57: A256.
3. Brownstein, B. H., Silverman, G. A., Little, R. A., Burke, D. T., Korsmeyer, S. J., Schlessinger, D., and Olson, M. V. (1989). Isolation of single-copy human genes from a library of yeast artificial chromosome clones. Science 244: 1348-1351.
4. Chang, E., Welch, S., Luna, J., Giacalone, J., and Francke, U. (1993). Generation of a human chromosome 18-specific YAC clone collection and mapping of 55 unique YACs by FISH and fingerprinting. Genomics 17: 393-402.
5. Cohen, M. M., Jr. (1989). Perspectives on holoprosencephaly. Part I. Epidemiology, genetics, and syndromology. Teratology 40: 211-235.
6. Craig, J. M., and Bickmore, W. A. (1994). The distribution of CpG islands in mammalian chromosomes. Nature Genet. 7: 376-382.
7. DeMyer, W., and Zeman, W. (1963). Alobar holoprosencephaly (arhinencephaly) with median cleft lip and palate. Clinical nosologic and electroencephalographic considerations. Conf. Neurol. 23: 1-36.
8. DeMyer, W., Zeman, W., and Palmer, C. G. (1964). The face predicts the brain: Diagnostic significance of median facial anomalies for holoprosencephaly (arhinencephaly). Pediatrics 34: 256-263.
9. Fantes, J. A., Bickmore, W. A., Fletcher, J. M., Ballesta, F., Hanson, I. M., and Van Heyningen, V. (1992). Submicroscopic deletions at the WAGR locus, revealed by nonradioactive in situ hybridization. Am. J. Hum. Genet. 51: 1286-1294.
10. Francis, F., Zehetner, G., Hoglund, M., and Lehrach, H. (1994). Construction and preliminary analysis of the ICRF human P1 library. Genetic Anal. Techniques Appl. 11: 148-157.
11. Gozes, I., and Brenneman, D. E. (1989). VIP: Molecular biology and neurobiological function. Mol. Neurobiol. 3: 202-235.
12. Gozes, I., McCune, S. K., Jacobson, L., Warren, D., Moody, T. W., Fridkin, M., and Brenneman, D. E. (1991). An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J. Pharmacol. Exp. Ther. 257: 959-966.
13. Gressens, P., Hill, J. M., Gozes, I., Fridkin, M., and Brenneman, D. E. (1993). Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 362: 155-158.
14. Gressens, P., Hill, J. M., Paindaveine, B., Gozes, I., Fridkin, M., and Brenneman, D. E. (1994). Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse. J. Clin. Invest. 94: 2020-2027.
15. Gurrieri, F., Trask, B. J., Vandenengh, G., Krauss, C. M., Schinzel, A., Pettenati, M. J., Schindler, D., Dietzband, J., Vergnaud, G., Scherer, S. W., Tsui, L. C., and Muenke, M. (1993). Physical mapping of the holoprosencephaly critical region on chromosome 7q36. Nature Genet. 3: 247-251.
16. Hatziioannou, A. G., Krauss, C. M., Lewis, M. B., and Halazonetis, T. D. (1991). Familial holoprosencephaly associated with a translocation break at chromosomal position 7q36. Am. J. Med. Genet. 40: 201-205.
17. Hill, R. E., Shaw, P. H., Barth, R. K., and Hastie, N. D. (1985). A genetic locus closely linked to a protease inhibitor gene complex controls the level of multiple RNA transcripts. Mol. Cell. Biol. 5: 2114-2122.
18. Hing, A. V., Helms, C., and Donis-Keller, H. (1993). VNTR and microsatellite polymorphisms within the subtelomeric region of 7q. Am. J. Hum. Genet. 53: 509-517.
19. Inagaki, N., Yoshida, H., Mizuta, M., Mizuno, N., Fujii, Y., Gonoi, T., Miyazaki, J.-I., and Seino, S. (1994). Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc. Natl. Acad. Sci. USA 91: 2679-2683.
20. Ishihara, T., Shigemoto, R., Mori, K., Takahashi, K., and Nagata, S. (1992). Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811-819.
21. Kofman-Alfaro, S., Speed, R. M., Boyle, S., and Chandley, A. C. (1994). Condensation behaviour of the human X chromosome in male germ cells and Sertoli cells examined by fluorescence in situ hybridization. Chromosome Res. 2: 439-444.
22. Kunz, J., Scherer, S. W., Klawitz, I., Soder, S., Du, Y.-Z., Speich, N., Kalff-Suske, M., Heng, H. H. Q., Tsui, L.-C., and Grzeschik, K.-H. (1994). Regional localization of 725 human chromosome 7-specific yeast artificial chromosome clones. Genomics 22: 439-448.
23. Kurtzman, D. N., van Dyke, D. L., Rich, C. A., and Weiss, L. (1987). Duplication 3p21 → 3pter and cyclopia. Am. J. Med. Genet. 27:33-37.
24. 2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334: 3-8.
25. Lynch, S. A., Bond, P. M., Copp, A. J., Kirwan, W. O., Nour, S., Balling, R., Mariman, E., Burn, J., and Strachan, T. (1995). A gene for autosomal dominant sacral agenesis maps to the holoprosencephaly region at 7q36. Nature Genet. 11: 93-95.
26. Magistretti, P. J., and Schorderet, M. (1984). VIP and noradrenaline act synergistically to increase cyclic AMP in cerebral cortex. Nature 308: 280-282.
27. Miyata, A., Arimura, A., Dahl, R. R., Minamino, N., Uehara, A., Jiang, L., Culler, M. D., and Coy, D. H. (1989). Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164: 567-574.
28. Muenke, M. (1994). Holoprosencephaly as a genetic model for normal craniofacial development. Dev. Biol. 5: 504-509.
29. Muenke, M., Gurrieri, F., Bay, C., Yi, D. H., Collins, A., Johnson, V. P., Hennekam, R. C. M., Schaefer, G. B., Weik, L., Lubinsky, M. S., Daack-Hirsch, S., Moore, C. A., Dobyns, W. B., Murray, J. C., and Price, R. A. (1994). Linkage of a human brain malformation, familial holoprosencephaly, to chromosome 7 and evidence for genetic heterogeneity. Proc. Natl. Acad. Sci. USA 91: 8102-8106.
30. Ogi, K., Kimura, C., Onda, H., Arimura, A., and Fujino, M. (1990). Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP). Biochem. Biophys. Res. Commun. 173: 1271-1279.
31. Overhauser, J., Mitchell, H. F., Zackai, E. H., Tick, D. B., Rojas, K., and Muenke, M. (1995). Physical mapping of the holoprosencephaly critical region in 18p11.3. Am. J. Hum. Genet. 57:1080-1085.
32. Punnett, H. H., Kistenmacher, M. L., Miller, R. C., Greene, A. E., and Coriell, L. L. (1979). A (7;18) translocation. 46, XY. Cytogenet. Cell Genet. 24: 126.
33. Quik, M., Iversen, L. L., and Bloom, S. R. (1978). Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain. Biochem. Pharmacol. 27: 2209-2213.
34. Riethman, H. C., Spais, C., Buckingham, J., Grady, D., and Moyzis, R. K. (1993). Physical analysis of the terminal 240 kb of DNA from human chromosome 7q. Genomics 17: 25-32.
35. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). "Molecular Cloning: A Laboratory Manual," Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
36. Scherer, S. W., Tompkins, B. J. F., and Tsui, L.-C. (1992). A human chromosome 7-specific genomic DNA library in yeast artificial chromosomes. Mamm. Genome 3: 179-181.
37. 2 receptor messenger RNA in the rat brain and pituitary gland as assessed by in situ hybridization. Neuroscience 67: 409-418.
38. Shivers, B. D., Görcs, T. J., Gottschall, P. E., and Arimura, A. (1991). Two high affinity binding sites for pituitary adenylate cyclase activating polypeptide have different tissue distributions. Endocrinology 128: 3055-3065.
39. Siebert, J. R., Cohen, M. M., Jr., Sulik, K. K., Shaw, C.-M., and Lemire, R. J. (1990). "Holoprosencephaly: An Overview and Atlas of Cases," Wiley-Liss, New York.
40. Spengler, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburg, P. H., and Journot, L. (1993). Differential signal transduction by 5 splice variants of the PACAP receptor. Nature 365: 170-175.
41. Sreedharan, S. P., Huang, J.-X., Cheung, M.-C., and Goetzl, E. J. (1995). Structure, expression and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc. Natl. Acad. Sci. USA 92: 2939-2943.
42. Sreedharan, S. P., Patel, D. R., Huang, J. X., and Goetzl, E. J. (1993). Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. Biochem. Biophys. Res. Commun. 193: 546-553.
43. Stoffel, M., Espinosa, R., Trabb, J. B., Lebeau, M. M., and Bell, G. I. (1994). Human type I pituitary adenylate cyclase activating polypeptide receptor (ADCYAP1R): Localization to chromosome band 7p14 and integration into the cytogenetic, physical, and genetic map of chromosome 7. Genomics 23: 697-699.
44. Straub, S. G., and Sharp, G. W. G. (1994). Evidence for a novel mechanism of action of VIP and PACAP to stimulate insulin release. Diabetologia 37: A22.
45. Sulik, K. K., Dehart, D. B., Rogers, J. M., and Chernoff, N. (1995). Teratogenicity of low-doses of all-trans-retinoic acid in presomite mouse embryos. Teratology 51: 398-403.
46. Svoboda, M., Tastenoy, M., Van Rampelbergh, J., Goossens, J. F., De Neef, P., Waelbroeck, M., and Robberecht, P. (1994). Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem. Biophys. Res. Commun. 205: 1617-1624.
47. Taylor, A. I. (1968). Autosomal trisomy syndromes: A detailed study of 27 cases of Edwards' syndrome and 27 cases of Patau's syndrome. J. Med. Genet. 5: 227-252.
48. Tsui, L.-C., Donnis-Keller, H., and Grzeschik, K.-H. (1995). Report of the 2nd International Workshop on Human Chromosome-7 Mapping 1994. Cytogenet. Cell Genet. 71: 1-21.
49. Usdin, T. B., Bonner, T. I., and Mezey, E. (1994). Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135: 2662-2680.
50. Wei, X., and Sulik, K. K. (1993). Pathogenesis of craniofacial and body-wall malformations induced by ochratoxin-A in mice. Am. J. Med. Genet. 47: 862-871.